According to The Stock Sniper (@Ultra_Calls), Biomerica (BMRA) reported real-world data showing a 49% reduction in IBS symptoms using its inFoods IBS system, which utilizes a first-of-its-kind real-time patient feedback technology. This positive clinical outcome positions BMRA as a strong biotech play, potentially increasing trading volume and investor interest. As biotech moves often spill into the crypto sector through health-tech and AI token narratives, traders should watch for increased sentiment in related crypto assets. (Source: @Ultra_Calls on Twitter, May 22, 2025)